Deal Alert: India Innovation Fund invests in life science technology company Shantani Proteome Analytic

From the Press Release:

With it’s focus on supporting innovation driven start-ups in technology and life sciences with early stage investment, the India Innovation Fund (IIF) (www.indiainnovationfund.in) along with Blume Ventures as co-investor, has made an investment in Shantani Proteome Analytics Pvt. Ltd.(http://www.shantani.com). Incubated at the National Chemical Laboratories’ Venture Center at Pune, Shantani develops advanced technology applications for use by drug discovery organisations for drug target discovery. Shantani also develops in-house drug discovery programs in defined therapeutic areas. Shantani has been founded by a management team with global scientific and business expertise.

Shantani’s proprietary chemical proteomics technology platform is used to identify and validate a few but rightful targets (cellular binding partners) of drugs and drug like bioactive molecules in a very short period of time allowing savings of 50-70 per cent in cost and time over existing strategies. It is also valuable for drug repositioning purposes and for identifying off-target interactions of a drug to understand its toxicity profile.

Rajesh Rai, Chief Executive Office, India Innovation Fund, said, “We are excited to partner with Dr.Saxena and the Shantani team. Shantani has developed a unique technology platform with significant benefits for drug design and development. We look forward to supporting the company through the IIF network.”

Dr.Chaitanya Saxena, Chief Executive Officer and Board of Director, Shantani Proteome Analytics Pvt. Ltd. said, “We have an innovative and exciting technology in the niche area of drug (target) discovery. However to grow our business we were not only looking for capital but the right partners with the understanding of technology driven businesses and a strong network in life sciences to help take our start-up to next stage. IIF led funding came with all those ingredients”

PE-VC investments decline 8% to $6.2 B in Q1'24

Press Release: Private Equity - Venture Capital (PE-VC) firms invested over $6.2 Billion (across 205 deals) in Indian companies during the first three months of 2024, shows data from Venture Intelligence , a research service focused on private company financials, transactions, and their valuations. (Note: These figures include Venture Capital type investments, but exclude PE investments in Real Estate). The investment amount represents a 8% fall over the $6.7 Billion (across 242 deals) invested in the same period during 2023 and also down by 6% when compared to the immediate previous quarter (which witnessed $6.6 Billion being invested across 200 deals). Deal volumes in Q1'24 also declined 15% compared to Q1'23 and were up by 3% compared to the immediate previous quarter. Q1’24 witnessed 8 mega deals ($100 M+ rounds) worth $3.5 Billion, compared to 17 such investments (worth $3.6 Billion) in Q1’23 and 15 such deals (worth $4.1 Billion) in the immediate previous quarter. Th

AZB tops League Table for Legal Advisors to PE deals in H1’24

Trilegal and Khaitan & Co. claim the No.2 & No.3 slots AZB & Partners (AZB) topped the Venture Intelligence League Table for Legal Advisor to Private Equity Transactions in H1 2024 advising 41 deals worth $5.4 Billion. It was followed by Trilegal ($5.1 Billion across 54 deals) and Khaitan & Co. (4.8 Billion across 46 deals) in the second and third spot respectively. Cyril Amarchand Mangaldas (CAM) ($2.9 Billion across 34 deals) and Talwar Thakore & Associates ($2.4 Billion across 9 deals) completed the top five. Among the larger Private Equity deals during H1’2024, Khaitan & Co., Talwar Thakore & Associates, S&R Associates ,and Trilegal a dvised the $2 Billion acquisition of the Indian business of American Tower Corporation by Brookfield which was the largest PE-VC investment in 2024 . AZB advised the $900 Million acquisition of Altimetrik by TPG Capital and the $840 Million acquisition of Healthium Medtech by KKR . Resolut Partners , Khaitan &

Avendus tops League Table for Transaction Advisors to PE deals in H1'24

Citi and Ambit claim the No.2&3 slots Avendus topped the Venture Intelligence League Table for Transaction Advisor to Private Equity Transactions in H1’2024 advising 12 deals worth $2.4 Billion. Citi stood second, having advised 1 deal worth $2 Billion. Ambit followed with 7 deals worth $797 million. Kotak Mahindra Capital ($735 million across 2 deals) and Ernst & Young ($657 million across 7 deals) completed the top five for H1’ 2024. The Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A transactions advised by Financial and Legal Advisory firms. Among the larger deals in the latest quarter, Citi, KPMG , Ernst & Young advised $2 Billion acquisition of the Indian business of American Tower Corporation by Brookfield . Avendus, Ernst & Young, JM Financial, Barclays and KPMG advised $ 554 million acquisition of Shriram Housing Finance by Warburg

Citi tops League Table for Transaction Advisors to M&A deals in H1'24

Ernst & Young and Avendus claim the No.2 & No.3 slots Citi , which advised the $2 Billion acquisition of the Indian business of American Tower Corporation by Brookfield, topped the Venture Intelligence League Table for Transaction Advisors to M&A Deals during H1 2024. Ernst & Young stood second advising 8 deals worth $1.5 billion. Avendus followed with 7 deals worth $1.2 billion. KPMG ($1.1 billion across 5 deals) and JM Financial ($900 million across 4 deals) completed the top five. The Venture Intelligence League Tables , the first such initiative exclusively tracking transactions involving India-based companies, are based on the value of PE and M&A transactions advised by Financial and Legal Advisory firms. Among the other larger M&A deals in H1 2024 (other than the ATC-Brookfield deal) , Ernst & Young, KPMG and Deloitte advised $1.1 Billion acquisition in PNC Infratech 12 Road Projects by Highways Infrastructure Trust . Kotak Mahindra Capital,

AZB & Partners tops League Table for Legal Advisors to M&A deals in H1’24

Khaitan & Co. and J Sagar Associates claim the No.2 & No.3 slots AZB & Partners topped the Venture Intelligence League Table for Legal Advisor to M&A Transactions during H1 2024 advising 37 deals worth $14.8 Billion. It was followed by Khaitan & Co. ($12.8 Billion across 32 deals) and J Sagar Associates (JSA) ($9.8 Billion across 13 deals). Cyril Amarchand Mangaldas (CAM) ($6.2 Billion across 38 deals) and Trilegal ($4.8 Billion across 20 deals) completed the top five. Among the largest M&A deals during H1 2024, AZB, JSA and Khaitan & Co. advised $8.5 Billion acquisition of Disney Hotstar by Reliance Jio . S&R Associates , Talwar Thakore & Associates (TTA), Khaitan & Co. and Trilegal advised the $2 Billion buyout deal of ATC India by Canadian infrastructure investor Brookfield Asset Management . CAM advised the $1.3 Billion in the acquisition of a further stake in Ambuja Cement by Adani Enterprises . Among foreign firms, Kirkland &a

The Venture Intelligence Blog

Search This Blog